Newsfeeds - Spark Newswire

1 minute read

Events
News

Lantern Pharma Announces Abstract On Effectiveness Of LP-284 In Hematologic Cancers Accepted For Presentation At The 63rd American Society Of Hematology Annual Meeting

Today, 4:38 AM

Lantern Pharma (NASDAQ:LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform to transform the cost, pace, and timeline of oncology drug

LTRN

7 minute read

Earnings Scheduled For November 1, 2021

By Benzinga Insights

Today, 4:38 AM

Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter.

ADC

2 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 4:38 AM

AGRX

2 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 4:38 AM

AVGR

9 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For October 7, 2021

By Benzinga Insights

Today, 4:38 AM

ALLY

1 minute read

HC Wainwright & Co. Initiates Coverage On Lantern Pharma with Buy Rating, Announces Price Target of $32

By Benzinga Newsdesk

Today, 4:38 AM

HC Wainwright & Co. analyst Michael King initiates coverage on Lantern Pharma (NASDAQ:LTRN) with a Buy rating and announces Price Target of $32.

LTRN

5 minute read

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer’s Sleep Disorder Drug Filing Accepted For Review, Voyager’s Licensing Options Deal

By Shanthi Rexaline

Today, 4:38 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5)

ABEO

6 minute read

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout

By Shanthi Rexaline

Today, 4:38 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4)

ADTX

1 minute read

From BZ’s Small Cap Healthcare Conference: Lantern Pharma President, Director & CEO, Panna Sharma Begins Speaking

By Zoltan Suranyi

Today, 4:38 AM

Click To Tune In Here... https://www.youtube.com/watch?v=KS30Mcu5ei8

LTRN

7 minute read

The Daily Biotech Pulse: AbbVie’s Migraine Drug OK’d By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug

By Shanthi Rexaline

Today, 4:38 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 28)

ABBV